Andreas Schalhorn

Title: Innovations by Andreas Schalhorn in Tumor Therapy

Introduction

Andreas Schalhorn is a notable inventor based in Planegg, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of tumor therapies. With a total of 2 patents, his work focuses on the determination of apoptotic products in patients undergoing therapy.

Latest Patents

Schalhorn's latest patents include innovative methods for determining apoptotic products in samples taken from patients. One of his inventions involves correlating the concentration of apoptotic products with the effectiveness of therapy, which serves as a follow-up for treatment. This method specifically assesses the concentration of nucleosomes in serum samples of tumor patients to evaluate the effectiveness of tumor therapy. Additionally, his inventions are applicable for patients undergoing radiotherapy or chemotherapy, as well as those recovering from acute ischemic events or hypothermia treatment.

Career Highlights

Andreas Schalhorn is currently associated with Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. His work has been instrumental in advancing methods that enhance the understanding of therapy effectiveness in cancer treatment.

Collaborations

Schalhorn has collaborated with esteemed colleagues such as Stefan Holdenrieder and Martin Busch, contributing to the development of innovative diagnostic methods.

Conclusion

Andreas Schalhorn's contributions to the field of tumor therapy through his patents reflect his commitment to improving patient outcomes. His innovative methods for determining the effectiveness of therapies are paving the way for advancements in medical diagnostics.